In a noteworthy development from the Texas judicial system, a local judge has denied two out-of-state attorneys from BakerHostetler the opportunity to participate in a high-profile case involving the U.S. Food and Drug Administration. The case, which challenges the FDA’s alleged favoritism towards major pharmaceutical companies by blocking affordable alternatives to the weight loss medication Ozempic, has attracted significant attention. The attorneys’ request to join the case “pro hac vice” was rejected due to their “frequent” legal activities in Texas, which the judge deemed excessive for the purpose of temporary admission.
For further insights into this legal decision, and its implications for out-of-state legal practitioners, the original article is available on Law360.